Arcutis Biotherapeutics Inc.

09/24/2024 | Press release | Distributed by Public on 09/24/2024 06:04

FDA Accepts Arcutis’ Supplemental New Drug Application for ZORYVE® (roflumilast) Foam for the Treatm